Cargando…
Tumor Microenvironment and Genes Affecting the Prognosis of Temozolomide-Treated Glioblastoma
Glioblastoma (GBM) is the most frequent primary brain tumor in adults and has a poor prognosis due to its resistance to Temozolomide (TMZ). However, there is limited research regarding the tumor microenvironment and genes related to the prognosis of TMZ-treated GBM patients. This study aimed to iden...
Autores principales: | Jang, Yena, Cheong, Wooyong, Park, Gyurin, Kim, Yeongmin, Ha, Junbeom, Ahn, Sangzin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966340/ https://www.ncbi.nlm.nih.gov/pubmed/36836422 http://dx.doi.org/10.3390/jpm13020188 |
Ejemplares similares
-
Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2020) -
Polymer–Temozolomide Conjugates as Therapeutics
for Treating Glioblastoma
por: Ward, Sarah M., et al.
Publicado: (2018) -
Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide
por: Robins, H. Ian, et al.
Publicado: (2018) -
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
por: Ly, K. Ina, et al.
Publicado: (2018) -
Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
por: Kim, Hee Yeon, et al.
Publicado: (2019)